We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open6,115.5
High6,130
Low6,055.5
Prev. Close6,108
Avg. Traded Price6,103.13
Volume1,67,723

MARKET DEPTH

info2
Total bid39,268.00
Total ask31,740.00
OrdersQtyBid
521696105
146104.5
136104
4156103.5
2316103
AskQtyOrders
6106376
6106.511
6107227
6107.5770
6108443

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

6,055.503 hours ago
6,130.00an hour ago
arrow

LOWER/UPPER CIRCUITS

5,497.50
6,718.50
arrow
Divis Laboratories Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 0.89%, in the last year to ₹8,184 Cr. Its sector's average revenue growth for the last fiscal year was 12.27%.
noteQuarterly Revenue,rose 25.01% YoY to ₹2,401 Cr. Its sector's average revenue growth YoY for the quarter was 10.03%.
noteQuarterly Net profit,rose 64.53% YoY to ₹589 Cr. Its sector's average net profit growth YoY for the quarter was 21.29%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 15.13%
Net profit growth 5Y CAGR : 3.41%

STOCK RETURNS

info
Versus Nifty 50
1 w
+2.05%
vs
-0.36%
1 mth
+4.10%
vs
+2.21%
3 mth
+11.13%
vs
+4.71%
6 mth
+3.41%
vs
-1.23%
1 yr
+50.72%
vs
+6.16%
3 yr
+31.72%
vs
+39.4%
5 yr
+154.41%
vs
+156.26%

ANALYST RATING

Aggregated across 100 coverages
Buy
Hold
Sell
12.5%
75%
12.5%
Powered by Trendlyne.
Divis Laboratories Ltd Top mutual funds holding
arrow
Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world. The company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
personal

Grow your wealth with more research recommendations

+91